Effects of cGMP and the nitric oxide donors glyceryl trinitrate and sodium nitroprusside on contractions in vitro of isolated myometrial tissue from pregnant women
Authors:
- L. M. WardLWL. M. Ward
- W. MartinWMW. Martin
- A. D. CameronACA. D. Cameron
- J. C. McGrathJMJ. C. McGrath
- I A GreerIGI A Greer
- I. T. CameronICI. T. Cameron
Open Access
- 1 July 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in Reproduction
- Vol. 110 (2) , 249-254
Abstract
The purpose of this study was to determine the relaxant effects in vitro of two nitric oxide donors, glyceryl trinitrate and sodium nitroprusside, which are currently available for use in vivo, on contractions of non-labouring myometrium from pregnant women. Since nitric oxide also mediates relaxation by increasing the concentration of cGMP, sensitivity to 8-bromo-cGMP (a cGMP analogue) was also determined. The effects of the K+-channel opener lemakalim and of the Ca2+-channel blocker nifedipine were studied for comparison. After the addition of glyceryl trinitrate (0.1–100 μmol l−1), sodium nitroprusside (0.1–100 μmol l−1) or 8-bromo-cGMP (0.001–3 mmol l−1), the spontaneous rhythmic contractility of myometrial strips was inhibited in a concentrationdependent manner: the maximum inhibition produced by the highest tested concentration of each drug was 40 ± 7%, 53 ± 8% and 39 ± 8% of the original degree of contraction, respectively. Myometrial contractions were completely abolished by lemakalim and by nifedipine and verapamil at concentrations of ≥ 10−5 mol l−1. The nitric oxide donors, glyceryl trinitrate and sodium nitroprusside, attenuate myometrial contractions and are therefore useful as tocolytic agents. However, at equimolar concentrations in vitro, the ability of glyceryl trinitrate and sodium nitroprusside to attenuate myometrial contractions is less than that of lemakalin, nifedipine and verapamil. Controlled trials are required to determine the side-effects and clinical efficacy of each of these agents in vivo.Keywords
This publication has 12 references indexed in Scilit:
- The role of endogenous nitric oxide synthesis in contractility of term or preterm human myometriumBJOG: An International Journal of Obstetrics & Gynaecology, 1997
- Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancyAmerican Journal of Obstetrics and Gynecology, 1995
- Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donorThe Lancet, 1994
- Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscleNature, 1994
- Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri.Proceedings of the National Academy of Sciences, 1994
- The effects of potassium channel openers on isolated pregnant human myometrium before and after the onset of labor: Potential for tocolysisAmerican Journal of Obstetrics and Gynecology, 1993
- Effects of cGMP on [Ca2+]i, myosin light chain phosphorylation, and contraction in human myometriumAmerican Journal of Physiology-Cell Physiology, 1991
- A comparison of tocolysis with nifedipine or ritodrine: Analysis of efficacy and maternal, fetal, and neonatal outcomeAmerican Journal of Obstetrics and Gynecology, 1990
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Pharmacologic inhibition of preterm laborAmerican Journal of Obstetrics and Gynecology, 1979